
Mingxin Xie
Articles
-
Apr 4, 2024 |
onlinelibrary.wiley.com | Hairui Wang |Shuang Luo |Mingxin Xie |Zhao Chen
Jincun Zhao State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510182 P. R. ChinaSearch for more papers by this author
ACE2 Receptor‐Targeted Inhaled Nanoemulsions Inhibit SARS‐CoV‐2 and Attenuate Inflammatory Responses
Jan 4, 2024 |
onlinelibrary.wiley.com | Hairui Wang |Shuang Luo |Mingxin Xie |Zhao Chen
Conflict of Interest The authors declare no conflict of interest. Supporting Information Filename Description adma202311537-sup-0001-SuppMat.pdf2.9 MB Supporting Information References 1, , , , , J. Hepatol. 2021, 74, 168. 2, Drugs 2020, 80, 1355. 3, , , , , , , Expert Rev. Clin. Pharmacol. 2021, 14, 95. 4, , , , , , , , Acta Pharmacol. Sin. 2021, 42, 1195. 5a) , , , , , , , , JCI Insight 2019, 4, e127474; b) , , Immunol. Lett. 2002, 84, 63.
ACE2 Receptor‐Targeted Inhaled Nanoemulsions Inhibit SARS‐CoV‐2 and Attenuate Inflammatory Responses
Jan 4, 2024 |
pericles.pericles-prod.literatumonline.com | Hairui Wang |Shuang Luo |Zhao Chen |Mingxin Xie
Conflict of Interest The authors declare no conflict of interest. Supporting Information Filename Description adma202311537-sup-0001-SuppMat.pdf2.9 MB Supporting Information References 1, , , , , J. Hepatol. 2021, 74, 168. 2, Drugs 2020, 80, 1355. 3, , , , , , , Expert Rev. Clin. Pharmacol. 2021, 14, 95. 4, , , , , , , , Acta Pharmacol. Sin. 2021, 42, 1195. 5a) , , , , , , , , JCI Insight 2019, 4, e127474; b) , , Immunol. Lett. 2002, 84, 63.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →